Advances in Molecular Pathology: Advances, cartea 6-1
Editat de Gregory J. Tsongalisen Limba Engleză Hardback – 20 oct 2023
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Hardback (2) | 906.70 lei 5-7 săpt. | |
| Elsevier – 7 noi 2022 | 906.70 lei 5-7 săpt. | |
| Elsevier – 20 oct 2023 | 906.87 lei 5-7 săpt. |
Din seria Advances
- 5%
Preț: 719.57 lei - 5%
Preț: 906.84 lei - 5%
Preț: 1234.51 lei - 5%
Preț: 931.55 lei - 5%
Preț: 1231.58 lei - 5%
Preț: 1163.93 lei - 5%
Preț: 1162.67 lei - 5%
Preț: 1232.37 lei - 5%
Preț: 1274.14 lei - 5%
Preț: 1127.64 lei - 25%
Preț: 736.57 lei - 25%
Preț: 669.97 lei - 30%
Preț: 985.61 lei - 5%
Preț: 822.83 lei - 30%
Preț: 976.09 lei - 25%
Preț: 666.27 lei - 25%
Preț: 589.98 lei - 25%
Preț: 708.79 lei - 25%
Preț: 735.14 lei - 25%
Preț: 859.95 lei - 25%
Preț: 806.57 lei - 25%
Preț: 790.51 lei - 25%
Preț: 808.28 lei - 25%
Preț: 870.06 lei - 30%
Preț: 871.07 lei - 5%
Preț: 493.16 lei - 30%
Preț: 595.74 lei - 25%
Preț: 974.77 lei - 25%
Preț: 670.57 lei - 25%
Preț: 807.45 lei - 33%
Preț: 849.29 lei - 30%
Preț: 857.52 lei - 5%
Preț: 854.81 lei - 25%
Preț: 983.64 lei - 25%
Preț: 688.34 lei - 25%
Preț: 799.28 lei - 25%
Preț: 907.36 lei - 5%
Preț: 906.79 lei - 5%
Preț: 909.16 lei - 25%
Preț: 593.78 lei - 5%
Preț: 854.03 lei - 30%
Preț: 856.00 lei - 25%
Preț: 884.68 lei - 33%
Preț: 854.05 lei - 25%
Preț: 835.65 lei - 5%
Preț: 906.70 lei - 5%
Preț: 492.43 lei - 5%
Preț: 907.69 lei - 27%
Preț: 594.28 lei - 5%
Preț: 1317.29 lei
Preț: 906.87 lei
Preț vechi: 1296.96 lei
-30%
Puncte Express: 1360
Preț estimativ în valută:
160.38€ • 188.20$ • 139.10£
160.38€ • 188.20$ • 139.10£
Carte tipărită la comandă
Livrare economică 02-16 martie
Specificații
Cuprins
The Landscape of Clinical Whole Genome Sequencing and the Emergence of Rapid Genetic Diagnosis in Critical Care
Blastic Plasmacytoid Dendritic Cell Neoplasm: Advances in Molecular Markers and Treatments
Molecular Classification of Diffuse Large B Cell Lymphoma: Impact on Prognosis and Treatment
B-Lymphoblastic Leukemia/Lymphoma: Newly Defined Entities and Subtypes by Molecular Methods
Molecular Diagnostics for Invasive Fungal Infections: Barriers to Widespread Adoption and Opportunities for Improvement
Recently Updated Sexually Transmitted Infection Screening Guidelines and Impact on Molecular Diagnostics
Quantitative Viral Load Monitoring: How far are We from Commutable Results?
The Current State of Pharmacoeconomics and Reimbursement for Pharmacogenomics
Long-read Sequencing for Germline Pharmacogenomic Testing
Practical Approaches to Pharmacogenomics in Patients Using Vitamins/Supplements and Medical Marijuana
Computer-Based Simulation of DNA Short[1]Read Next-Generation Sequencing: A Review of Software from a Clinical Perspective
Minimal Residual Disease Testing in Solid Tumors,
Mutational Signatures in Solid Tumors
Multi-Cancer Early Detection: Blood-Based Screening, Multiomics, Machine Learning, and New Clinical Pathways
Rapid Whole Genome Sequencing in Critically Ill Newborns
Molecular Diagnosis of Emerging Pathogens: Policy and Practical Considerations for Laboratorians
Blastic Plasmacytoid Dendritic Cell Neoplasm: Advances in Molecular Markers and Treatments
Molecular Classification of Diffuse Large B Cell Lymphoma: Impact on Prognosis and Treatment
B-Lymphoblastic Leukemia/Lymphoma: Newly Defined Entities and Subtypes by Molecular Methods
Molecular Diagnostics for Invasive Fungal Infections: Barriers to Widespread Adoption and Opportunities for Improvement
Recently Updated Sexually Transmitted Infection Screening Guidelines and Impact on Molecular Diagnostics
Quantitative Viral Load Monitoring: How far are We from Commutable Results?
The Current State of Pharmacoeconomics and Reimbursement for Pharmacogenomics
Long-read Sequencing for Germline Pharmacogenomic Testing
Practical Approaches to Pharmacogenomics in Patients Using Vitamins/Supplements and Medical Marijuana
Computer-Based Simulation of DNA Short[1]Read Next-Generation Sequencing: A Review of Software from a Clinical Perspective
Minimal Residual Disease Testing in Solid Tumors,
Mutational Signatures in Solid Tumors
Multi-Cancer Early Detection: Blood-Based Screening, Multiomics, Machine Learning, and New Clinical Pathways
Rapid Whole Genome Sequencing in Critically Ill Newborns
Molecular Diagnosis of Emerging Pathogens: Policy and Practical Considerations for Laboratorians